English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

In this study we compared, in a prospective randomized trial, the results, in terms of anatomic and functional correction, of two procedures for Stress urinary incontinence (SUI) with cystocele 3-4: four-corner retropubic correction versus anterior repair with medial duplication of the pubocervical fascia and pubourethral ligaments plication. From June 1996 through April 2000, 80 patients affected by SUI type 1 and 2 according to Blaivas with urethrocystocele of 3 or 4 degrees according to the halfway system were randomly assigned to one of the following treatments (randomization 2:1): -1. Anterior colporrhaphy according to Nichols (52 women); -2. Four-corner bladder and urethral retropubic suspension according to Raz (28 women). The follow-up time of patients varied from 280 to 1670 days. The SUI relapse occurred in 26.9% of patients who underwent Nichols’ technique, against the 14.3% found in the other group, with a statistically significant difference (p<0.01). By contrast, the anatomic correction of vaginal profile did not result significantly different in the two groups analyzed. We concluded that the four-corner procedure is more successful in terms of incontinence cure

urogynaecologia international journal

FOUR-CORNER BLADDER AND URETHRAL RETROPUBIC SUSPENSION VERSUS ANTERIOR COLPORRHAPHY IN THE CORRECTION OF STRESS URINARY INCONTINENCE WITH URETHROCYSTOCELE 3-4. RANDOMIZED CLINICAL TRIAL